Cart
sales@molnova.com
Adibendan
CAS No. 100510-33-6
Adibendan ( Adibendanum )
Catalog No. M27748 CAS No. 100510-33-6
Adibendan is a phosphodiesterase III inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 264 | Get Quote |
|
| 5MG | 404 | Get Quote |
|
| 10MG | 593 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1251 | Get Quote |
|
| 100MG | 1692 | Get Quote |
|
| 500MG | 3402 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAdibendan
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdibendan is a phosphodiesterase III inhibitor.
-
DescriptionAdibendan is a phosphodiesterase III inhibitor.(In Vitro):Adibendan exerted a concentration-dependent (0.03 –300 μM) positive inotropic effect in papillary muscles (EC50 = 1.3 μM) which was only partially reversible. The IC50 values for the inhibition of PDE1 or PDE2 were more than 60-fold higher.
-
SynonymsAdibendanum
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABAB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number100510-33-6
-
Formula Weight278.3
-
Molecular FormulaC16H14N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C)C(=O)Nc2cc3nc([nH]c3cc12)-c1ccncc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.C A Drew, et al. Inhibition of baclofen binding to rat cerebellar membranes by phaclofen, saclofen, 3-aminopropylphosphonic acid and related GABAB receptor antagonists. Neurosci Lett. 1990 May 18;113(1):107-10.
molnova catalog
related products
-
Taxifolin
(+)-Taxifolin,Flavonoid, antioxidant. Inhibits lipogenesis in cancer cells, most likely by targeting fatty acid synthase activity.
-
Aplidine
Aplidine possesses antiviral activity against SARS-CoV-2(IC90 = 0.88 nM). Aplidine is a potent anti-cancer agent by targeting eukaryotic translation elongation factor 1 Alpha 2(EEF1A2, Kd = 80?nM).
-
Goserelin acetate
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
